More Than $1.1 Million Donated for Cancer Research and Clinical Training at Johns Hopkins

MCLEAN, VA--(Marketwired - October 03, 2014) - The immixGroup Foundation announced today it has raised $125,000 to support cancer research, education, and patient care at Johns Hopkins. The foundation is a non-profit 501(c)(3) organization affiliated with immixGroup, Inc. immixGroup helps technology companies do business with the government.

These proceeds will fund the immixGroup Foundation Surgical Oncology Fellowship in the Department of Surgery at Johns Hopkins. The fellowship, launched by the immixGroup Foundation in 2009, provides funding for an individual post-doctoral research fellow and equips him or her with the skills to become a leader in the field of academic surgical oncology. This two-year program incorporates a year of clinical training followed by a year dedicated to cancer research. To learn more about the fellowship and the fellow supported, watch this video developed by Johns Hopkins.

The 2014 immixGroup Foundation Fellow, Dr. Megan Winner received her undergraduate and medical degrees from Washington University in St. Louis, then moved to New York for her general surgery residency at Columbia University/New York Presbyterian Hospital. There she was awarded a post-doctoral research fellowship in Cancer Epidemiology from the Mailman School of Public Health, where she also completed a Master's of Science in Biostatistics. During her fellowship she studied the epidemiology and treatments of complications of advanced colon and ovarian cancer and addressed issues in screening, diagnosis, staging, treatment, cost utilization, and quality of life in patients with pancreatic cancer and premalignant tumors. Before joining the Johns Hopkins Surgical Oncology fellowship, Dr. Winner served as Administrative Chief of her residency program.

Last year's immixGroup Foundation Fellow, Dr. Andrew J. Page, arrived at Johns Hopkins in July 2013. Dr. Page attended the Emory School of Medicine and completed a general surgery residency at Emory as well. During his time at Emory, Dr. Page also excelled in a dedicated two-year basic science fellowship in transplant immunology. In the upcoming year, Dr. Page plans to continue his training with advanced surgical oncology and focus his interests in gastric, colorectal, esophageal, and pancreatic cancer. Dr. Page's second year will have a special emphasis on patient centered outcomes research and foregut surgery. As part of this further training, he will also learn state of the art minimally invasive and robotic surgical techniques.

More than 100 local businesses and individuals also contributed gift certificates, vacations, golf products, and other items which were auctioned or raffled during a reception following the tournament.

"We are excited to continue funding the immixGroup Foundation Surgical Oncology Fellowship," said Jeff Copeland, Executive Chairman of immixGroup, Inc. "We have witnessed unbelievable generosity from our fellow members of the public sector technology community, government executives, friends, and supporters to raise capital and increase awareness for a very worthy cause. We are proud to know our efforts have allowed Dr. Megan Winner and Dr. Andrew Page to contribute their work to the Johns Hopkins team as they search for a cure for this devastating disease."

"Through our care of patients, our research, and educating the surgeons of tomorrow, we are committed to eradicating colorectal cancer and other gastrointestinal cancers. Our fight against cancer here is personal," said Dr. Timothy M. Pawlik, Chief of the Division of Surgical Oncology at Johns Hopkins. "We truly appreciate the partnership of the immixGroup Foundation and the tournament's sponsors, donors, players, volunteers, and members of the executive planning committee, for joining us in this fight. The support our fellows receive through this event enables us to take a proactive stance against this disease. We enjoy coming out every year at this incredible event to thank our generous sponsors, spread some awareness, and have some fun at the same time."

immixGroup helps technology companies do business with the government. immixGroup's unique platform of services enables software and hardware manufacturers and their channel partners to grow their public sector business and accelerate the sales cycle. Since 1997, immixGroup has delivered the specialized resources and expertise these companies need to increase their revenue, support their demand creators, and operate efficiently. And government agencies trust immixGroup to provide leading IT products through their preferred contracts and business partners. For more information, contact immixGroup, Inc. at 703-752-0610, via email at info@immixgroup.com, or on the Web at www.immixgroup.com.

To fulfill its social responsibility as a company, immixGroup® created the immixGroup Foundation, a non-profit 501(c)(3) organization. Since 2005, immixGroup and its foundation have donated more than $1.1 million for cancer research and actively support numerous charitable causes at both the local and national levels.